MiR-21 inhibitor sensitizes human OSCC cells to cisplatin

Molecular Biology Reports

Volumn 39, Issue 5, 2012, Pages 5481-5485

  Wang, Wei ^a   Songlin, Piao ^a   Sun, Yao ^a   Zhang, Bin ^a   Jinhui, Wang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cisplatin; miR 21; OSCC; Sensitivity

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CISPLATIN; MICRORNA 21; MICRORNA; MIRN21 MICRORNA, HUMAN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG SENSITIVITY; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MOUTH SQUAMOUS CELL CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG SCREENING; GENETICS; METABOLISM; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DOWN-REGULATION; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MOUTH NEOPLASMS; OLIGONUCLEOTIDES, ANTISENSE;

EID: 84863734321     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1350-9     Document Type: Article

References (18)

1. Friedman RC, Farh KK, Burge CB et al (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19:92-105
2. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
3. Croce CM (2009) Causes and consequences of micro-RNA dysregulation in cancer. Nat Rev Genet 10:704-714
4. Alvarez-Garcia I, Miska EA (2005) MicroRNA functions in animal development and human disease. Development 132: 4653-4662
5. Cho WC (2007) OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 6:60
6. Dai Z, Huang Y, Sadee W (2004) Growth factor signaling and resistance to cancerchemotherapy. Curr Top Med Chem 4: 1347-1356
7. Huang Y, Anderle P, Bussey KJ et al (2004) Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Res 64:4294-4301
8. Filipowicz W, Jaskiewicz L, Kolb FA et al (2005) Post-transcriptional gene silencing by siRNAs and miRNAs. Curr Opin Struct Biol 15:331-341
9. Blower PE, Chung JH, Verducci JS et al (2008) MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther 7:1-9
10. Baulcombe D (2002) DNA events: an RNA microcosm. Science 297:2002-2003
11. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big roll in gene regulation. Nat Rev Genet 5:522-531
12. Sontheimer EJ (2005) Assembly and function of RNA silencing complexes. Nat Rev Mol Cell Biol 6:127-138
13. Bentwich I (2005) A postulated role for microRNA in cellular differentiation. FASEB J 19:875-879
14. Ciafre SA, Galardi S, Mangiola A et al (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334:1351-1358
15. Chan JA, Krichevsky AM, Kosik KS (2005) Microrna-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029-6033
16. Sorrentino A, Liu CG, Addario A et al (2008) Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol Oncol 111:478-486
17. Meng F, Henson R, Lang M, Wehbe H et al (2006) Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130:2113-2129
18. Moriyama T, Ohuchida K, Mizumoto K et al (2009) MicroRNA- 21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther 8:1067-1074